This website uses cookies to improve your experience. By clicking “Accept” you are agreeing to our Privacy Policy.
Human immunodeficiency virus type 1 (HIV-1) ranks as the most common type of HIV which destroys the CD4 immune cells, thereby attacking the body's immune system. The market is driven by the increasing cases of HIV-1, expanding treatment options, and substantial investments to advance HIV care. The market also benefits from the introduction of affordable generic drugs and advanced antiretroviral therapies. Moreover, the rising healthcare expenditure, robust regulatory support, and heightened public awareness are projected to impact the market dynamics.
In 2023, around 39.9 million individuals were living with the human immunodeficiency virus, with approximately 1.3 million people estimated to acquire the infection in the year. Further, about 630,000 people died due to HIV-related causes. The rising prevalence of HIV-1 infection, with ongoing transmission reported in all countries globally, is propelling the demand for antiretroviral therapy and preventive measures, thus contributing to the overall market growth.
Based on the drug class, the market segmentation includes nucleoside-analog reverse transcriptase inhibitors, non-nucleoside reverse transcriptase inhibitors, protease inhibitors, and integrase inhibitors, among others. Protease inhibitors, such as darunavir and atazanavir, hold a significant market share due to their efficacy in the management of treatment-resistant HIV. These medications are taken in combination with other drugs for patients who have developed resistance to the other drug classes. On the other hand, integrase inhibitors are quickly gaining significant market demand owing to their effectiveness, fewer side effects, and simple dose regimens.
The market report also offers insights based on the route of administration, end user, distribution channel, and region.
The market segmentation by region includes the United States, EU-4 (Germany, France, Italy, Spain), and the United Kingdom, Japan, and India. The United States is one of the leading markets which can be attributed to the significant burden of HIV infections and the rising emphasis on HIV care in the region. The market also benefits from the presence of a well-established healthcare system and key market players, stimulating growth and innovation in this regional market. Additionally, the rising entry of generic antiretroviral medications is anticipated to boost the market expansion in the country in the forecast period.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which is constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124